Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Reducing the risk of unnecessary chemo

09.11.2010
A fundamental principle of medicine is: "first, do no harm." However, for doctors who treat breast cancer, this is easier said than done.

Every year, almost 22,000 Canadian women are diagnosed with breast cancer — their treatment usually involves surgery to remove a tumour and then chemotherapy to reduce the risk of cancer returning. But studies show that for most patients with early stage breast cancer, chemotherapy following surgery is totally unnecessary and therefore does more harm than good.

Identifying whether a patient's cancer is at low or high risk of recurring would help doctors reduce unnecessary treatments for low risk patients. This could have a huge impact on a patient's quality of life and also significantly reduce the cost of health care.

Did you know?

Chemotherapy can be devastating both physically and emotionally. Side effects of breast cancer chemotherapy range from nausea, vomiting and hair loss to mouth sores, menopause, infertility, numbness and aching of the joints, hands and feet.

Currently, most doctors assess a patient's prognosis using their age and "tumour grade," but this approach doesn't work very well. Now, NRC researchers have developed a tool to determine which breast cancer patients have little risk of their disease recurring. The tool — an algorithm that identifies "gene expression signatures" or biomarkers that can predict low risk tumours with 87-100 percent accuracy in different groups of patients — has the potential to virtually eliminate unnecessary chemotherapy.

To conduct their study, which appeared in a recent issue of Nature Communications, Dr. Edwin Wang and his colleagues at the NRC Biotechnology Research Institute in Montreal (NRC-BRI) used published data on gene expression profiles from more than 1000 breast cancer samples. "Every tumour has a gene expression profile, which indicates how the patient's genes have changed," he explains. "We combined this data with information on the patient's outcome — such as whether the original tumour spread and how long the person survived — to develop our algorithm."

The NRC team now hopes to see its algorithm applied in a clinical setting. "We have a provisional patent on the intellectual property and we would like to get a Canadian company to license it and turn it into a kit format," says Dr. Maureen O'Connor of NRC-BRI, who co-authored the study. "We've had interest expressed from more than one company so far."

Dr. O'Connor adds that the NRC algorithm could be adapted to other types of cancer where over-treatment is common, such as prostate cancer. "Prostate cancer in particular is usually not an aggressive disease, but the treatment can be extreme," she says. "We would like to develop a test that can predict with 99 percent accuracy whether a patient's cancer is not aggressive, so they can make the best decision about whether to proceed with treatment right away."

In future, the algorithm may also help pave the way toward personalized therapy for cancer patients. "On average, every cancer patient has 14-16 mutated genes," says Dr. Wang. "Based on their unique genetic signature, we hope to figure out which mutations to target to block the cancer process in each patient."

NRC Media Relations | EurekAlert!
Further information:
http://www.nrc-cnrc.gc.ca

Further reports about: Canadian Light Source NRC NRC-BRI algorithm breast cancer cancer patients

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>